| Role |
Name |
Disclosure |
Details |
| Author | Thomas Lafeber, MD, Consulting Staff, Wellstar Infectious Disease LLC | Nothing to disclose | Details | | Coauthor | J Robert Cantey, MD, Chief of Infectious Disease, Veterans Affairs Medical Center, Director, Professor, Department of Medicine, Division of Infectious Diseases, Medical University of South Carolina | Nothing to disclose | Details | | Medical Editor | Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Aaron Glatt, MD, Professor of Clinical Medicine, New York Medical College; Chief Medical Officer, Departments of Medicine and Infectious Diseases, New Island Hospital | Nothing to disclose | Details | | CME Editor | Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital | Nothing to disclose | Details | | Chief Editor | Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Thomas Lafeber, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| J Robert Cantey, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Aaron Glatt, Managing Editor |
The contributor discloses no conflict of interest. |
|